|
TimTec assembled small targeted compound collection of over 500 compounds-analogs based on three validated O-GlcNAc Transferase inhibitors (following the results of the discovery at Department of Microbiology and Molecular Genetics, HUMS) Compounds with proven activity are available from stock: ST045849 MW 447.00 MF C23H27ClN2O3S 3-(2-adamantanylethyl)-2-[(4-chlorophenyl)azamethylene]-4-oxo-1,3-thiazaperhyd roine-6-carboxylic acid ![3-(2-adamantanylethyl)-2-[(4-chlorophenyl)azamethylene]-4-oxo-1,3-thiazaperhyd roine-6-carboxylic acid](/images/stories/structures/ST045849.png "3-(2-adamantanylethyl)-2-[(4-chlorophenyl)azamethylene]-4-oxo-1,3-thiazaperhyd roine-6-carboxylic acid")
ST060266 MW 289.67 MF C14H8ClNO4 phenyl 5-chloro-2-oxo-3-hydrobenzoxazole-3-carboxylate 
References: Gross, B.J, Kraybill, B.C., Walker, S. Discovery of O-GlcNAc Transferase Inhibitors. Department of Microbiology and Molecular Genetics, Harvard Medical School. JACS Communications, published on Web 09/29/05; J. Am. Chem. Soc. 2005, 127, 14588-14589. ST078925, analog-substitute to validated inhibitor #6, Figure 3. of the paper MW 406.53 MF C22H18N2O2S2 4-[(3-cyano-4-(2-thienyl)-2-5,6,7,8-tetrahydroquinolylthio)methyl]benzoic acid 
|
